The Discounted Cash Flow (DCF) valuation of Regenxbio Inc (RGNX) is (137.03) USD. With the latest stock price at 11.99 USD, the upside of Regenxbio Inc based on DCF is -1242.9%.
Based on the latest price of 11.99 USD and our DCF valuation, Regenxbio Inc (RGNX) is a sell. selling RGNX stocks now will result in a potential gain of 1242.9%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.2% - 8.1% | 7.1% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (354.52) - (86.91) | (137.03) |
| Upside | -3056.8% - -824.9% | -1242.9% |